Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University School of Medicine, Durham, NC, USA.
The Duke Office of Clinical Research, Duke University School of Medicine, Durham, NC, USA.
Clin Nutr ESPEN. 2022 Aug;50:247-254. doi: 10.1016/j.clnesp.2022.05.008. Epub 2022 May 23.
BACKGROUND & AIMS: Continuous renal replacement therapy (CRRT) is essential to the management of acute kidney injury (AKI) in critical illness. Unfortunately, large quantities of micronutrients are shown to be lost in CRRT effluent. Current literature describes serum micronutrient values in CRRT patients to be below-reference range, yet seldom compares such values to other critically ill populations unexposed to CRRT. The aim of this study was to describe and compare the prevalence of micronutrient and carnitine deficiencies in critically ill patients at high malnutrition risk exposed to CRRT to a group of patient unexposed to CRRT.
A retrospective chart review was conducted at Duke University Hospital using the electronic medical record. The study group consisted of patients at high malnutrition risk requiring intensive care unit (ICU) admission from 01/01/2017-12/31/2018 with one or more of the following serum micronutrient levels checked: carnitine, copper, zinc, selenium, and vitamins B1, B6, B9, and C. Micronutrient deficiencies were defined as below the reference range and carnitine deficiencies were interpreted as an acyl to free carnitine ratio (ACFR) of >0.4.
106 ICU patients met inclusion criteria and 46% were exposed to CRRT. At least one micronutrient deficiency was reported in 90% of CRRT patients compared to 61% patients unexposed to CRRT (p = 0.002). A greater percentage of copper (p < 0.001) and carnitine (p < 0.001) deficiencies were found among patients exposed to CRRT, while more zinc deficiencies were noted among non-CRRT patients (p = 0.001).
The vast majority of CRRT patients presented with micronutrient deficiencies. Clinicians should have a heightened awareness of the risk for serum copper, carnitine, and vitamin B6 deficiencies among CRRT patients. Further prospective and randomized-controlled trials are needed to better define this new category of malnutrition and test supplementation strategies to address and prevent these clinically-relevant deficiencies.
连续肾脏替代疗法(CRRT)是危重病急性肾损伤(AKI)治疗的关键。然而,大量的微量营养素在 CRRT 废液中被发现丢失。目前的文献描述了 CRRT 患者的血清微量营养素值低于参考范围,但很少将这些值与未接受 CRRT 的其他危重患者进行比较。本研究的目的是描述和比较暴露于 CRRT 的高营养不良风险的危重症患者与未暴露于 CRRT 的患者的微量营养素和肉碱缺乏的患病率。
本研究使用电子病历对杜克大学医院进行了回顾性图表审查。研究组包括 2017 年 1 月 1 日至 2018 年 12 月 31 日期间因高营养风险需要入住重症监护病房(ICU)的患者,他们的血清微量营养素水平检查了一项或多项,包括肉碱、铜、锌、硒和维生素 B1、B6、B9 和 C。微量营养素缺乏定义为低于参考范围,肉碱缺乏定义为酰基辅酶 A 到游离肉碱的比值(ACFR)>0.4。
106 名 ICU 患者符合纳入标准,其中 46%的患者接受了 CRRT。与未接受 CRRT 的患者(61%)相比,接受 CRRT 的患者至少有一种微量营养素缺乏(90%)(p=0.002)。接受 CRRT 的患者铜(p<0.001)和肉碱(p<0.001)缺乏的比例更高,而未接受 CRRT 的患者锌缺乏的比例更高(p=0.001)。
绝大多数 CRRT 患者存在微量营养素缺乏。临床医生应该高度警惕 CRRT 患者血清铜、肉碱和维生素 B6 缺乏的风险。需要进一步的前瞻性和随机对照试验来更好地定义这一新的营养不良类别,并测试补充策略来解决和预防这些具有临床意义的缺乏症。